Key Highlights

  • CDT Equity (NASDAQ:CDT) changed hands at USD 0.0493 during the November 4, 2026 session, a 26.42% decline on about 3.54 million shares. Its Market Value stood near USD 459.61 thousand.
  • An 8-K signed on November 4, 2026 schedules a 1-for-20 reverse split to take effect November 5 at 5:00 p.m. ET, with split-adjusted quotes beginning at the open on November 6.
  • The consolidation reduces shares outstanding from 20,357,283 to roughly 1,017,864 and comes after a 1-for-25 split that became effective September 28, 2026.
  • A prospectus supplement dated November 4, 2026 registers 673,023 shares for resale by selling holders, and the company gets none of the proceeds.

Session Move (down USD 0.0177, 26.42%)

CDT Equity (NASDAQ:CDT) was quoted at USD 0.0493 in regular trading on November 4, 2026, a 26.42% fall. Working backward gives a prior close of USD 0.0670, so the decline equals USD 0.0177 per share (calculated). A prospectus supplement filed the same day gives a last reported price of USD 0.067 on November 3, 2026, consistent with that math. Quote data indicated about 3.54 million shares traded and relative Volume of 0.12, which means turnover was far below normal. The size of that drop on a company valued near USD 459.61 thousand illustrates how few trades are required to push the quote around.

The Reverse Split Notice

The 8-K states that a certificate of amendment went through on November 2, 2026, and the filing was signed November 4, 2026. The 1-for-20 consolidation becomes effective at 5:00 p.m. ET on November 5, 2026, and shares will trade split-adjusted from the open on November 6, 2026 under the unchanged CDT symbol, now carrying CUSIP 20678X809. Outstanding shares drop from 20,357,283 to around 1,017,864, with cash paid in lieu of fractional shares. A reverse split leaves each holder's proportional stake unchanged, since the per-share price rises as the count falls, and it is intended to restore compliance with the exchange's bid requirement. Holders previously endorsed possible later splits, with the board choosing when.

Earlier Split, Resale Supply and Trading Risks

This represents the company's second consolidation of shares within about six weeks. The 1-for-25 split that went into effect September 28, 2026 left about 1,013,515 shares outstanding, per the company release. Since then the total has risen to 20,357,283, and the share price has sunk to just a few cents. CDT Equity is a biopharmaceutical business, formerly Conduit Pharmaceuticals, headquartered in Naples, Florida. The prospectus supplement covers 673,023 resale shares, among them 140,925 that may be issued when senior secured convertible Debt converts. Conversions and resales can add supply. For a microcap with few trades, spreads may be wide and quotes may flip, so the drop should not be taken as a trend.

Where Things Stand

CDT Equity (NASDAQ:CDT) is down 26.42% intraday on November 4, 2026. The filings suggest dilution pressure linked to a repeat share consolidation within six weeks, not a trial readout or an Earnings release, and no pipeline news dated November 2 to November 4 turned up. The consolidation takes effect November 5, so the quote will mechanically jump on November 6 while an investor's slice of the company stays the same. Holders should track whether the quote stays above the exchange floor after the adjustment, how many shares arrive via note conversions, and whether the company spells out financing terms.